Find trials
Search tips

Challenges in Medication Coverage in Pediatric Epilepsy

Overview

About this study

The purpose of this study is to (1) determine how often children with epilepsy have delays in obtaining prescribed anti-seizure medications due to cost and prior authorization process (2) determine whether delays in obtaining medications, if present, affect seizure control and  (3) determine whether delays in obtaining medications lead to seizure-related complications or hospitalizations.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  1. Age 0-21 years, inclusive
  2. Childhood onset epilepsy
  3. Treated at Mayo Clinic Rochester for epilepsy by one of the pediatric epileptologists
  4. Willing to participate

Exclusion Criteria: 

  1. No epilepsy diagnosis
  2. Unable to complete written questionnaires
  3. Unwilling to complete questionnaire

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Elaine Wirrell, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20319154

Mayo Clinic Footer